Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 378
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2158hnRNP KProteinHumanUpregulated in HCC DiagnosticEarly HCC vs Late HCC p < 0.01Serum22760167
2159hnRNP K, AFPProteinHumanUpregulated in HCC DiagnosticEarly HCC vs Late HCC p < 0.01Serum22760167
2164Apo-A4ProteinHumanDownregulated in HCC patients DiagnosticHCC v/s other liver disease (cirrhosis/ALD) p < 0.01Plasma21160983
2165APO-A1ProteinHumanUpregulated in HCC patients DiagnosticHCC v/s other liver disease (cirrhosis/ALD) p < 0.01Plasma21160983
2166APO-A1, Apo-A4ProteinHumanAPO-A4 Upregulated and APO-A1 downregulated in HCC patients DiagnosticHCC v/s other liver disease (cirrhosis/ALD) p < 0.01Plasma21160983
2178miR-122miRNAHumanvariable expression between different hepatoma cell lines: PLC/PRF/5, Huh-1, and Hep40 exhibited very high levels of miR-122, whereas others, such as Hep3B and HepG2, expressed little or did not express miR-122 at all (e.g. SNU387, and SNU398) ; in HCC patients miR-122 was specifically repressed in Diagnostic and PrognosticNormal vs HCC; associated with survival, tumor size and differentiation status p < 0.001Tissue and Cells 19617899
2179lamin B1ProteinHumanUpregulated in liver cancer patients Diagnostic and PrognosticNormal vs HCC; significantly associated with the increased number of tumor nodules , the size of tumors, and tumor stage p < 0.01Plasma19522540
2180circCDK13circRNAsHumanSuppressed expression in liver cancer DiagnosticNormal cell line vs cancer cell line p < 0.05Tissue29658568
2181miR-101-3p, miR-106b-3p, miR-1246miRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Plasma29632649
2182miR-101-3pmiRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Plasma29632649
2183miR-1246miRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Plasma29632649
2184miR-106b-3pmiRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Plasma29632649
2185miR-101-3p, miR-106b-3pmiRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Plasma29632649
2186miR-101-3p, miR-1246miRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Plasma29632649
2187miR-106b-3p, miR-1246miRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Plasma29632649
2188miR-101-3pmiRNAHumanUpregulated in HCC DiagnosticHCC v/s Control p < 0.001Plasma29632649
2189miR-101-3p, miR-106b-3p, miR-1246miRNAHumanUpregulated in HCC DiagnosticHCC v/s Control p < 0.001Plasma29632649
2190miR-1246miRNAHumanUpregulated in HCC DiagnosticHCC v/s Control p < 0.001Plasma29632649
2191miR-106b-3pmiRNAHumanUpregulated in HCC DiagnosticHCC v/s Control p < 0.001Plasma29632649
2192miR-101-3p, miR-106b-3pmiRNAHumanUpregulated in HCC DiagnosticHCC v/s Control p < 0.001Plasma29632649
2193miR-101-3p, miR-1246miRNAHumanUpregulated in HCC DiagnosticHCC v/s Control p < 0.001Plasma29632649
2194miR-106b-3p, miR-1246miRNAHumanUpregulated in HCC DiagnosticHCC v/s Control p < 0.001Plasma29632649
2195miR-101-3pmiRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Serum29632649
2196miR-106b-3pmiRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Serum29632649
2197miR-101-3p, miR-106b-3pmiRNAHumanUpregulated in HCC DiagnosticHCC v/s Cirrhosis p < 0.001Serum29632649
2198miR-26amiRNAHuman cell lineDownregulated in HepG2 cells Potential Diagnostic *Normal cell line vs Liver cancer cell line p < 0.05Cells29430178
2200AFP, (with cut off 0.9 of AFP in serum )ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2201BMK, (with cut off 0.40 BMK in Urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2202AFP, BMK, (with cut off 1.25 of AFP in serum and 0.25 BMK in urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2203AFP, BMK, (with cut off 1.20 of AFP in serum and 0.27 BMK in urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2204AFP, BMK, (with cut off 0.90 of AFP in serum and 0.40 BMK in urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2205AFP, BMK, (with cut off 1.65 of AFP in serum and 0.40 BMK n urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2206AFP, BMK, (with cut off 0.9 of AFP in serum and 0.75 BMK in urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2209ITGA2ProteinHumanUpregulated in HCC DiagnosticHBV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.0001Tissue28947976
2210BMP4ProteinHumanUpregulated in HCC DiagnosticHBV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.0001Tissue28947976
2211PLCB1ProteinHumanUpregulated in HCC DiagnosticHBV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.0001Tissue28947976
2212KDM6BProteinHumanDownregulated in HCC DiagnosticHBV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.0001Tissue28947976
2213MYCProteinHumanDownregulated in HCC DiagnosticHBV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.0001Tissue28947976
2214ITGA2ProteinHumanUpregulated in HCC DiagnosticHCV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.01Tissue28947976
2215BMP4ProteinHumanUpregulated in HCC DiagnosticHCV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.01Tissue28947976
2216PLCB1ProteinHumanUpregulated in HCC DiagnosticHCV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.01Tissue28947976
2217KDM6BProteinHumanDownregulated in HCC DiagnosticHCV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.001Tissue28947976
2218MYCProteinHumanDownregulated in HCC DiagnosticHCV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.0001Tissue28947976
2220AFP, DCPProteinHumanAFP upregulated in HCC DiagnosticNormal vs HCC, Cirrhosis p < 0.001Serum19852963
2221DCP, (> =40 mAU/mL)ProteinHumanDCP upregulated in HCC DiagnosticNormal vs HCC, Cirrhosis p < 0.001Serum19852963
2222DCP, (> =150 mAU/mL)ProteinHumanDCP upregulated in HCC DiagnosticNormal vs HCC, Cirrhosis p < 0.001Serum19852963
2223AFP, (> =20 ng/mL)ProteinHumanAFP and DCP upregulated in HCC DiagnosticNormal vs HCC, Cirrhosis p < 0.001Serum19852963
2224AFP, (> =200 ng/mL)ProteinHumanAFP and DCP upregulated in HCC DiagnosticNormal vs HCC, Cirrhosis p < 0.001Serum19852963
2225AFP, DCP, ( DCP with a cut-off value of 86 mAU/mL and AFP with a cut-off value of 21 ng/mL)ProteinHumanAFP and DCP upregulated in HCC DiagnosticHCC v/s Normal p < 0.001Serum25382443
2226AFP, (cut-off value of 21 ng/mL)ProteinHumanAFP upregulated in HCC DiagnosticHCC v/s Normal p < 0.001Serum25382443

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top